Sujal M. Patel - Mar 3, 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role: CEO, President, and Secretary, Director, 10%+ Owner
Signature: /s/ Matthew B. Murphy, as Attorney-in-Fact
Stock symbol: NAUT
Transactions as of: Mar 3, 2022
Transactions value $: $180,890
Form type: 4
Date filed: 3/4/2022, 04:39 PM
Previous filing: Feb 25, 2022
Next filing: May 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NAUT	Common Stock	Purchase	$180K	+50K	+0.51%	$3.60	9.91M	Mar 3, 2022	Direct	F1
transaction	NAUT	Common Stock	Options Exercise	$1K	+100	+0%	$10.00	9.91M	Mar 4, 2022	Direct
holding	NAUT	Common Stock						5.28M	Mar 3, 2022	By PFV I, LLC	F2
holding	NAUT	Common Stock						1.81M	Mar 3, 2022	By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NAUT	Stock Option (Right to Buy)	Options Exercise	$0	-100	-0.01%	$0.00	789K	Mar 3, 2022	Common Stock	100	$10.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.57 to $3.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2	Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
F3	Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
F4	Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 31, 2021.